Eckhardt S. Ferdinandi

720 total citations
30 papers, 484 citations indexed

About

Eckhardt S. Ferdinandi is a scholar working on Organic Chemistry, Pharmacology and Pharmacology. According to data from OpenAlex, Eckhardt S. Ferdinandi has authored 30 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 8 papers in Pharmacology and 8 papers in Pharmacology. Recurrent topics in Eckhardt S. Ferdinandi's work include Pharmacogenetics and Drug Metabolism (7 papers), Inflammatory mediators and NSAID effects (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Eckhardt S. Ferdinandi is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Inflammatory mediators and NSAID effects (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Eckhardt S. Ferdinandi collaborates with scholars based in United States, Canada and United Kingdom. Eckhardt S. Ferdinandi's co-authors include Mitchell N. Cayen, D. Dvornik, E. Greselin, Alfred Häßner, M. Kraml, George Just, William T. Robinson, Christopher A. Demerson, J. F. Douglas and J. J. Kneiss and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Eckhardt S. Ferdinandi

30 papers receiving 429 citations

Peers

Countries citing papers authored by Eckhardt S. Ferdinandi

Since Specialization

Citations

This map shows the geographic impact of Eckhardt S. Ferdinandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eckhardt S. Ferdinandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eckhardt S. Ferdinandi more than expected).

Fields of papers citing papers by Eckhardt S. Ferdinandi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eckhardt S. Ferdinandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eckhardt S. Ferdinandi. The network helps show where Eckhardt S. Ferdinandi may publish in the future.

Co-authorship network of co-authors of Eckhardt S. Ferdinandi

This figure shows the co-authorship network connecting the top 25 collaborators of Eckhardt S. Ferdinandi. A scholar is included among the top collaborators of Eckhardt S. Ferdinandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eckhardt S. Ferdinandi. Eckhardt S. Ferdinandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical toxicity and toxicokinetics of GTI-2040, a phosphorothioate oligonucleotide targeting ribonucleotide reductase R2 2010 ·Cancer Chemotherapy and Pharmacology ·Eckhardt S. Ferdinandi, Aikaterini Vassilakos, Yoon Lee, Jeff Lightfoot, (unknown), James R. Wright, Aiping Young	9
2	Non‐Clinical Pharmacology and Safety Evaluation of TH9507, a Human Growth Hormone‐Releasing Factor Analogue 2006 ·Basic & Clinical Pharmacology & Toxicology ·Eckhardt S. Ferdinandi, Paul Brazeau, (unknown), B. G. Procter, (unknown), P. Dubreuil	27
3	Pulmonary delivery of TH9507, a growth hormone releasing factor analogue, in the dog 2004 ·International Journal of Pharmaceutics ·Mendel Jansen, Ian A. Darby, Thierry Abribat, Patrice Dubreuil, Eckhardt S. Ferdinandi, John G. Hardy	11
4	Disposition of Radioactivity in Fischer 344 Rats after Single and Multiple Inhalation Exposure to [14C]Octamethylcyclotetrasiloxane ([14C]D4) 2000 ·Drug Metabolism and Disposition ·Kathleen P. Plotzke, (unknown), Eckhardt S. Ferdinandi, (unknown), Richard H. Reitz, Debra A. McNett, Robert G. Meeks	39
5	Virulizin-2gamma, a novel immunotherapeutic agent, in treatment of human pancreatic cancer xenografts. 2000 ·International Journal of Oncology ·Chun‐Jen Liu, Eckhardt S. Ferdinandi, (unknown), S. K. Joshi	8
6	Pharmacokinetics and Disposition of Methyl t-Butyl Ether in Fischer-344 Rats 1997 ·Journal of Applied Toxicology ·Mary J. Miller, Eckhardt S. Ferdinandi, (unknown), Larry S. Andrews, J. F. Douglas, J. J. Kneiss	34
7	Pharmacokinetics and disposition of the lipid-lowering drug acifran in normal subjects and in patients with renal failure 1990 ·Clinical Pharmacology & Therapeutics ·Mitchell N. Cayen, Eckhardt S. Ferdinandi, David Hicks, (unknown), (unknown), J.-E. Dubuc, M. Kraml, K. D. G. Edwards	3
8	Etodolac, a novel antiinflammatory agent. The syntheses and biological evaluation of its metabolites 1988 ·Journal of Medicinal Chemistry ·Leslie G. Humber, Eckhardt S. Ferdinandi, Christopher A. Demerson, (unknown), (unknown), Dominick Mobilio, (unknown), (unknown), (unknown)	36
9	Identification of the etodolac metabolite, 4-ureidoetodolac, in mouse, rat, dog, and man. 1987 ·Drug Metabolism and Disposition ·Eckhardt S. Ferdinandi, Donald G. Cochran, (unknown)	5
10	Disposition and biotransformation of¹⁴C-etodolac in man 1986 ·Xenobiotica ·Eckhardt S. Ferdinandi, Suren N. Sehgal, Christopher A. Demerson, J.-E. Dubuc, (unknown), D. Dvornik, (unknown)	26
11	Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeys. 1985 ·Drug Metabolism and Disposition ·Mitchell N. Cayen, David Hicks, Eckhardt S. Ferdinandi, M. Kraml, E. Greselin, D. Dvornik	14
12	Disposition of etodolac, other anti-inflammatory pyranoindole-1-acetic acids and furobufen in normal and adjuvant arthritic rats. 1982 ·Journal of Pharmacology and Experimental Therapeutics ·Eckhardt S. Ferdinandi, Mitchell N. Cayen, C.R. Pace-Asciak	16
13	The Metabolic Disposition of Etodolac in Rats, Dogs, and Man 1981 ·Drug Metabolism Reviews ·Mitchell N. Cayen, M. Kraml, Eckhardt S. Ferdinandi, E. Greselin, D. Dvornik	49
14	Studies on the disposition of diosgenin in rats, dogs, monkeys and man 1979 ·Atherosclerosis ·Mitchell N. Cayen, Eckhardt S. Ferdinandi, E. Greselin, D. Dvornik	39
15	Synthesis of [¹⁴C]labelled pyrano[3,4‐b]‐and thiopyrano[3,4‐b]indoles, and indeno[2,1‐c]pyran derivatives 1978 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Eckhardt S. Ferdinandi, David Hicks, (unknown), (unknown)	6
16	Synthesis of [14‐¹⁴C] dexclamol hydrochloride and [14‐¹⁴C] butaclamol hydrochloride 1978 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Eckhardt S. Ferdinandi, (unknown), (unknown)	1
17	Clofibrate and clofibric acid: comparison of the metabolic disposition in rats and dogs. 1977 ·Journal of Pharmacology and Experimental Therapeutics ·Mitchell N. Cayen, Eckhardt S. Ferdinandi, E. Greselin, William T. Robinson, D. Dvornik	44
18	Synthesis and antihypertensive activity of some thienylethanolamines 1976 ·Journal of Medicinal Chemistry ·Jehan F. Bagli, (unknown), Eckhardt S. Ferdinandi, Mitchell N. Cayen, (unknown), Thomas A. Pugsley, W. Lippmann	15
19	Preparation of [2‐¹⁴C]‐2‐(p‐chlorophenoxy)‐2‐methylpropionic acid and its ethyl ester, [¹⁴C] clofibrate 1975 ·Journal of Labelled Compounds ·Eckhardt S. Ferdinandi	4
20	A Synthesis of d,l-Prostaglandin E₂ Methyl Ester and Related Compounds 1971 ·Canadian Journal of Chemistry ·Eckhardt S. Ferdinandi, George Just	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact